Candace Rhodes
About Candace Rhodes
Candace Rhodes is a Principal BioEngineering Scientist at Boston Scientific with extensive experience in bioassays, bioreactors, and stem cell research.
Title: Principal BioEngineering Scientist
Candace Rhodes is currently serving as the Principal BioEngineering Scientist at Boston Scientific. She has been in this role since 2021, based in Marlborough, Massachusetts, United States. Her role involves leading bioengineering projects and contributing to the development and improvement of medical devices.
Professional Experience at Boston Scientific
Candace Rhodes rejoined Boston Scientific in 2021 as the Principal BioEngineering Scientist. Prior to this, she served as the Principal Scientist at the same company from 2015 to 2019. During her earlier tenure, she played a critical role in advancing various scientific and technological projects related to biomedical engineering.
Previous Roles in Bioengineering
Before her current role at Boston Scientific, Candace Rhodes worked at Cytiva as a Development Manager between 2020 and 2021 and at GE Healthcare in a similar role from 2019 to 2020. Earlier, she was the Director of Cell Biology at Harvard Apparatus Regenerative Technology from 2013 to 2015, and an Analytical/Process Scientist at Genzyme Biosurgery between 2011 and 2013. She also gained experience as a Scientist I at Garnet Biotherapeutics Inc. and conducted post-doctoral research at the University of Pittsburgh.
Education and Research Background
Candace Rhodes completed her PhD in Bioengineering from the University of Pittsburgh, where she also served as a Post-Doctoral Researcher and a Graduate Student Researcher. She holds a Bachelor of Science in Biomedical Engineering from the University of Rochester, where she gained initial research experience as an Undergraduate Researcher.
Expertise in Bioengineering
Candace Rhodes has extensive experience in developing in vitro cell-based functional bioassays and is adept with the development pipeline for biologic or combination biologic/device products. Her expertise extends to enhanced culture systems, specifically bioreactors, and she holds thorough knowledge of various stem cell types including human bone marrow-derived stem cells, adipose-derived stem cells, and neural stem cells.